Accuray Incorporated (0H8I.L)
USD 1.56
(3.01%)
USD 1.56
(3.01%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 142.61 Million USD | -4.21% |
| 2022 | 148.87 Million USD | -1.93% |
| 2021 | 151.8 Million USD | 10.59% |
| 2020 | 137.27 Million USD | 0.87% |
| 2019 | 136.08 Million USD | -15.25% |
| 2018 | 160.56 Million USD | -2.98% |
| 2017 | 165.49 Million USD | 9.48% |
| 2016 | 151.16 Million USD | -3.83% |
| 2015 | 157.18 Million USD | -5.69% |
| 2014 | 166.67 Million USD | 3.61% |
| 2013 | 160.87 Million USD | -11.14% |
| 2012 | 181.05 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 FY | 142.41 Million USD | -4.34% |
| 2023 Q2 | 39.86 Million USD | 6.94% |
| 2023 Q3 | 33.63 Million USD | -15.63% |
| 2023 Q4 | 31.63 Million USD | -5.95% |
| 2023 Q1 | 37.28 Million USD | -2.24% |
| 2022 Q4 | 38.13 Million USD | 7.11% |
| 2022 FY | 148.87 Million USD | -1.93% |
| 2022 Q3 | 35.6 Million USD | -11.57% |
| 2022 Q2 | 40.26 Million USD | 9.47% |
| 2022 Q1 | 36.77 Million USD | -10.23% |
| 2021 Q1 | 37.11 Million USD | -6.25% |
| 2021 Q2 | 38.64 Million USD | 4.13% |
| 2021 Q3 | 35.07 Million USD | -9.24% |
| 2021 Q4 | 40.97 Million USD | 16.81% |
| 2021 FY | 151.8 Million USD | 10.59% |
| 2020 Q3 | 34.89 Million USD | 11.24% |
| 2020 Q1 | 30.27 Million USD | -13.21% |
| 2020 Q4 | 39.58 Million USD | 13.45% |
| 2020 Q2 | 31.37 Million USD | 3.62% |
| 2020 FY | 137.27 Million USD | 0.87% |
| 2019 Q4 | 34.88 Million USD | 9.91% |
| 2019 Q1 | 37.5 Million USD | -11.0% |
| 2019 Q2 | 21.83 Million USD | -41.8% |
| 2019 FY | 136.08 Million USD | -15.25% |
| 2019 Q3 | 31.73 Million USD | 45.37% |
| 2018 Q4 | 42.14 Million USD | 11.87% |
| 2018 Q3 | 37.67 Million USD | -3.57% |
| 2018 Q2 | 39.06 Million USD | -9.22% |
| 2018 Q1 | 43.03 Million USD | -5.78% |
| 2018 FY | 160.56 Million USD | -2.98% |
| 2017 Q1 | 43.01 Million USD | 4.52% |
| 2017 FY | 165.49 Million USD | 9.48% |
| 2017 Q4 | 45.67 Million USD | 12.3% |
| 2017 Q3 | 40.67 Million USD | 0.68% |
| 2017 Q2 | 40.39 Million USD | -6.07% |
| 2016 Q4 | 41.14 Million USD | 13.32% |
| 2016 Q3 | 36.31 Million USD | -1.78% |
| 2016 Q2 | 36.97 Million USD | -3.08% |
| 2016 Q1 | 38.14 Million USD | -4.68% |
| 2016 FY | 151.16 Million USD | -3.83% |
| 2015 Q4 | 40.01 Million USD | 2.62% |
| 2015 Q1 | 41.95 Million USD | 0.49% |
| 2015 Q3 | 38.99 Million USD | -10.27% |
| 2015 Q2 | 43.45 Million USD | 3.59% |
| 2015 FY | 157.18 Million USD | -5.69% |
| 2014 FY | 166.67 Million USD | 3.61% |
| 2014 Q4 | 41.74 Million USD | 13.01% |
| 2014 Q1 | 44.46 Million USD | -0.07% |
| 2014 Q3 | 36.94 Million USD | -15.1% |
| 2014 Q2 | 43.51 Million USD | -2.15% |
| 2013 Q1 | 37.78 Million USD | -7.55% |
| 2013 Q3 | 39.98 Million USD | 1.99% |
| 2013 Q4 | 44.49 Million USD | 11.3% |
| 2013 FY | 160.87 Million USD | -11.14% |
| 2013 Q2 | 39.2 Million USD | 3.74% |
| 2012 Q4 | 40.87 Million USD | -14.65% |
| 2012 Q3 | 47.89 Million USD | -2.98% |
| 2012 Q2 | 49.36 Million USD | 0.0% |
| 2012 FY | 181.05 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | 61.438% |
| Align Technology, Inc. | 2.07 Billion USD | 93.133% |
| Elevance Health Inc. | 36.23 Billion USD | 99.606% |
| AxoGen, Inc. | 149.33 Million USD | 4.499% |
| Boston Scientific Corporation | 7.5 Billion USD | 98.1% |
| CVS Health Corporation | 40.68 Billion USD | 99.649% |
| Cardinal Health, Inc. | 5 Billion USD | 97.148% |
| Centene Corporation | 138.33 Billion USD | 99.897% |
| DaVita Inc. | 1.47 Billion USD | 90.324% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 99.686% |
| Hologic, Inc. | 1.26 Billion USD | 88.749% |
| Humana Inc. | 102.36 Billion USD | 99.861% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 86.95% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | 92.945% |
| Masimo Corporation | 867 Million USD | 83.551% |
| McKesson Corporation | 8.67 Billion USD | 98.356% |
| Patterson Companies, Inc. | 1.12 Billion USD | 87.349% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | 91.142% |
| ResMed Inc. | 1.36 Billion USD | 89.578% |
| Henry Schein, Inc. | 2.93 Billion USD | 95.144% |
| Teladoc Health, Inc. | 2.09 Billion USD | 93.179% |
| Universal Health Services, Inc. | 9.2 Billion USD | 98.451% |
| Veeva Systems Inc. | 1.25 Billion USD | 88.655% |
| Baxter International Inc. | 5.27 Billion USD | 97.295% |
| Becton, Dickinson and Company | 6.71 Billion USD | 97.875% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 95.186% |
| Danaher Corporation | 8.75 Billion USD | 98.371% |
| Stryker Corporation | 9.2 Billion USD | 98.451% |
| Medtronic plc | 16.12 Billion USD | 99.116% |